Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification
Medial vascular calcification has emerged as a key factor contributing to cardiovascular mortality in patients with chronic kidney disease (CKD). Vascular smooth muscle cells (VSMCs) with osteogenic transdifferentiation play a role in vascular calcification. Nicotinamide adenine dinucleotide phospha...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4eb960f8fe464f61b6384cfebf7bfc9f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4eb960f8fe464f61b6384cfebf7bfc9f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4eb960f8fe464f61b6384cfebf7bfc9f2021-11-25T17:54:58ZDextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification10.3390/ijms2222122771422-00671661-6596https://doaj.org/article/4eb960f8fe464f61b6384cfebf7bfc9f2021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12277https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Medial vascular calcification has emerged as a key factor contributing to cardiovascular mortality in patients with chronic kidney disease (CKD). Vascular smooth muscle cells (VSMCs) with osteogenic transdifferentiation play a role in vascular calcification. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitors reduce reactive oxygen species (ROS) production and calcified-medium–induced calcification of VSMCs. This study investigates the effects of dextromethorphan (DXM), an NADPH oxidase inhibitor, on vascular calcification. We used in vitro and in vivo studies to evaluate the effect of DXM on artery changes in the presence of hyperphosphatemia. The anti-vascular calcification effect of DXM was tested in adenine-fed Wistar rats. High-phosphate medium induced ROS production and calcification of VSMCs. DXM significantly attenuated the increase in ROS production, the decrease in ATP, and mitochondria membrane potential during the calcified-medium–induced VSMC calcification process (<i>p</i> < 0.05). The protective effect of DXM in calcified-medium–induced VSMC calcification was not further increased by NADPH oxidase inhibitors, indicating that NADPH oxidase mediates the effect of DXM. Furthermore, DXM decreased aortic calcification in Wistar rats with CKD. Our results suggest that treatment with DXM can attenuate vascular oxidative stress and ameliorate vascular calcification.En-Shao LiuNai-Ching ChenTzu-Ming JaoChien-Liang ChenMDPI AGarticledextromethorphansmooth muscle cellarterial calcificationBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12277, p 12277 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
dextromethorphan smooth muscle cell arterial calcification Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
dextromethorphan smooth muscle cell arterial calcification Biology (General) QH301-705.5 Chemistry QD1-999 En-Shao Liu Nai-Ching Chen Tzu-Ming Jao Chien-Liang Chen Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification |
description |
Medial vascular calcification has emerged as a key factor contributing to cardiovascular mortality in patients with chronic kidney disease (CKD). Vascular smooth muscle cells (VSMCs) with osteogenic transdifferentiation play a role in vascular calcification. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitors reduce reactive oxygen species (ROS) production and calcified-medium–induced calcification of VSMCs. This study investigates the effects of dextromethorphan (DXM), an NADPH oxidase inhibitor, on vascular calcification. We used in vitro and in vivo studies to evaluate the effect of DXM on artery changes in the presence of hyperphosphatemia. The anti-vascular calcification effect of DXM was tested in adenine-fed Wistar rats. High-phosphate medium induced ROS production and calcification of VSMCs. DXM significantly attenuated the increase in ROS production, the decrease in ATP, and mitochondria membrane potential during the calcified-medium–induced VSMC calcification process (<i>p</i> < 0.05). The protective effect of DXM in calcified-medium–induced VSMC calcification was not further increased by NADPH oxidase inhibitors, indicating that NADPH oxidase mediates the effect of DXM. Furthermore, DXM decreased aortic calcification in Wistar rats with CKD. Our results suggest that treatment with DXM can attenuate vascular oxidative stress and ameliorate vascular calcification. |
format |
article |
author |
En-Shao Liu Nai-Ching Chen Tzu-Ming Jao Chien-Liang Chen |
author_facet |
En-Shao Liu Nai-Ching Chen Tzu-Ming Jao Chien-Liang Chen |
author_sort |
En-Shao Liu |
title |
Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification |
title_short |
Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification |
title_full |
Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification |
title_fullStr |
Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification |
title_full_unstemmed |
Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification |
title_sort |
dextromethorphan reduces oxidative stress and inhibits uremic artery calcification |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/4eb960f8fe464f61b6384cfebf7bfc9f |
work_keys_str_mv |
AT enshaoliu dextromethorphanreducesoxidativestressandinhibitsuremicarterycalcification AT naichingchen dextromethorphanreducesoxidativestressandinhibitsuremicarterycalcification AT tzumingjao dextromethorphanreducesoxidativestressandinhibitsuremicarterycalcification AT chienliangchen dextromethorphanreducesoxidativestressandinhibitsuremicarterycalcification |
_version_ |
1718411860197244928 |